Reviewer comment: While these results suggest that antidiarrheal prophylaxis with loperamide decreases the incidence and severity of diarrhea, a higher incidence of constipation, fatigue, and nausea was reported in the loperamide cohort of Study 6201 compared to the neratinib arm of Study 3004.